• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2024, Vol. 26 ›› Issue (6): 792-796.DOI: 10.3969/j.issn.1671-2587.2024.06.014

Previous Articles     Next Articles

Identify the CisAB Subtype by PacBio Third-generation Sequencing Technology and Explore the Molecular Mechanism by Molecular Docking

XIA Yuexin1, SHAO Linnan1, LI Ning1, ZHOU Shihang1, LIU zhiyuan2   

  1. 1Dalian Blood Center, Dalian 116000,
    2Dalian Municipal Women and Children's Medical Center (Group), Dalian 116000
  • Received:2024-05-21 Online:2024-12-20 Published:2024-12-20

Abstract: Objective To identify a rare cisAB subtype by immunoserology and PacBio third-generation sequencing technology, and explore the molecular mechanism of amino acid mutations in cisAB glycosyltransferase by molecular docking. Methods The ABO phenotype was identified by immunoserological method, and the genotype was identified by three generation sequencing technology. The homologous modeling and molecular docking of cisAB01 glycosyltransferase were used to explore the structural changes of the glycosyltransferase after key amino acid mutations. Results The serological phenotype was AB. The gene sequencing showed that the genotype was cisAB.01/O.01.02. Homology modeling and molecular docking showed that p.Pro156Leu and p.Gly268Ala mutation of cisAB01 glycosyltransferase alter the spatial structure of the binding groove of catalytic active center. Conclusion The p.Pro156Leu and p.Gly268Ala mutation are key sites for the bifunctional activity of cisAB01 glycosyltransferase.

Key words: cisAB subtype, PacBio third-generation sequencing technology, Homology modeling, Molecular mechanism, Molecular docking

CLC Number: